BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $80,937 | -7.6% | 26,624 | 0.0% | 0.01% | -16.7% |
Q2 2023 | $87,593 | -37.6% | 26,624 | -39.7% | 0.01% | -14.3% |
Q1 2023 | $140,314 | -54.0% | 44,124 | 0.0% | 0.01% | -62.2% |
Q4 2022 | $305,338 | +9.3% | 44,124 | 0.0% | 0.04% | +15.6% |
Q3 2022 | $279,305 | +13.5% | 44,124 | -25.9% | 0.03% | +52.4% |
Q2 2022 | $246,000 | -64.0% | 59,524 | -57.7% | 0.02% | -27.6% |
Q1 2022 | $683,000 | -54.7% | 140,824 | -6.6% | 0.03% | -68.5% |
Q4 2021 | $1,507,000 | -65.7% | 150,824 | -34.5% | 0.09% | -67.3% |
Q3 2021 | $4,397,000 | -36.1% | 230,100 | +7.0% | 0.28% | -34.3% |
Q2 2021 | $6,876,000 | -4.2% | 215,000 | -9.7% | 0.43% | -5.7% |
Q1 2021 | $7,176,000 | +2993.1% | 238,000 | +18207.7% | 0.45% | +1094.7% |
Q4 2017 | $232,000 | – | 1,300 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |